Literature DB >> 3871616

Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens.

L M Pachman, J M Friedman, M L Maryjowski-Sweeney, O Jonnason, R M Radvany, G C Sharp, M A Cobb, N D Battles, W E Crowe, C W Fink.   

Abstract

Ninety children with definite juvenile dermatomyositis (JDMS), who had been HLA typed, were tested for the presence of tissue or organ-specific antibodies. Sixty had active disease at the time of study. The mean disease duration was 4 years, and 30 had soft tissue calcifications. The following autoantibodies were sought: thyroid, gastric parietal cells, smooth muscle, striated muscle, microsomes, mitochondria, DNA, extractable nuclear antigen, Sm, PM-1, antinuclear antibody (ANA), and rheumatoid factor. Only the ANA and PM-1 were more frequent in patients than in controls (P less than 0.0002 and P less than 0.001, respectively). Higher levels of immune complexes (P less than 0.01) were found in sera from patients with JDMS than in sera from controls and were correlated with the presence of ANA in patients (P less than 0.01). Soft tissue calcification was not associated with any autoantibody or HLA antigen, but with disease duration and activity (P less than 0.001 and P less than 0.05, respectively). There was no association between the occurrence of any autoantibody and the presence of HLA-B8 or DR3 among the white patients with JDMS. The frequency of autoantibodies in 43 full siblings of children with JDMS was not increased. We conclude that children with JDMS, with or without HLA-B8/DR3, do not show evidence of a generalized nonspecific antibody response to tissue antigens. The significance of the increased antibody to nuclear antigens ANA and PM-1 remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871616     DOI: 10.1002/art.1780280208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  Autoantibodies in juvenile dermatomyositis.

Authors:  E Martínez-Cordero; E Martínez-Miranda; D E Aguilar León
Journal:  Clin Rheumatol       Date:  1993-09       Impact factor: 2.980

2.  Altered immunoregulations in otosclerosis: presence of autoantibodies in otosclerotic sera samples.

Authors:  S Jesić; R Radulović; N Arsović
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

3.  Interferon-α induction and detection of anti-ro, anti-la, anti-sm, and anti-rnp autoantibodies by autoantigen microarray analysis in juvenile dermatomyositis.

Authors:  Imelda Balboni; Timothy B Niewold; Gabrielle Morgan; Cindy Limb; Maija-Leena Eloranta; Lars Rönnblom; Paul J Utz; Lauren M Pachman
Journal:  Arthritis Rheum       Date:  2013-09

4.  Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis.

Authors:  M R O'Gorman; L Bianchi; D Zaas; V Corrochano; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  2000-07

5.  Electric shock wave lithotripsy (ESWL) as a pain control measure in dermatomyositis with calcinosis cutis-old method, new discovery.

Authors:  Alice Y K Chan; Edmund Li
Journal:  Clin Rheumatol       Date:  2004-11-24       Impact factor: 2.980

6.  Flow cytometric analyses of the lymphocyte subsets in peripheral blood of children with untreated active juvenile dermatomyositis.

Authors:  M R O'Gorman; V Corrochano; J Roleck; M Donovan; L M Pachman
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

Review 7.  Laboratory evaluation of the inflammatory myopathies.

Authors:  L G Rider; F W Miller
Journal:  Clin Diagn Lab Immunol       Date:  1995-01

8.  Duration of chronic inflammation alters gene expression in muscle from untreated girls with juvenile dermatomyositis.

Authors:  Yi-Wen Chen; Rongye Shi; Nicholas Geraci; Sheela Shrestha; Heather Gordish-Dressman; Lauren M Pachman
Journal:  BMC Immunol       Date:  2008-07-31       Impact factor: 3.615

Review 9.  Consensus-based recommendations for the management of juvenile dermatomyositis.

Authors:  Felicitas Bellutti Enders; Brigitte Bader-Meunier; Eileen Baildam; Tamas Constantin; Pavla Dolezalova; Brian M Feldman; Pekka Lahdenne; Bo Magnusson; Kiran Nistala; Seza Ozen; Clarissa Pilkington; Angelo Ravelli; Ricardo Russo; Yosef Uziel; Marco van Brussel; Janjaap van der Net; Sebastiaan Vastert; Lucy R Wedderburn; Nicolaas Wulffraat; Liza J McCann; Annet van Royen-Kerkhof
Journal:  Ann Rheum Dis       Date:  2016-08-11       Impact factor: 19.103

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.